
The zzso zzso 13 zzso zzso zzso is a zzso zzso zzso not otherwise detected within the central nervous zzso Here, we describe a novel approach for targeting zzso zzso zzso with zzso zzso T cells zzso by their genetic modification to express a zzso zzso zzso zzso zzso zzso zzso or zzso Our zzso zzso incorporates an zzso zzso zzso for selective binding to zzso Human zzso zzso zzso display zzso zzso zzso function including tumor cell zzso zzso zzso production, and zzso zzso zzso The zzso zzso acid substitution of the zzso zzso of the zzso zzso zzso zzso with the capacity to discriminate between zzso zzso targets from targets expressing zzso In zzso the adoptive transfer of zzso zzso clones results in the zzso of established human zzso zzso zzso Pilot clinical trials have been initiated to evaluate the feasibility and safety of zzso delivery of zzso zzso redirected zzso clones in patients with zzso zzso Our zzso is a zzso of a new class of zzso zzso that signal through an engineered immune zzso composed of zzso zzso zzso bound to zzso zzso receptors on zzso 

